These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 18511248)

  • 1. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide.
    Quinten T; De Beer T; Almeida A; Vlassenbroeck J; Van Hoorebeke L; Remon JP; Vervaet C
    Drug Dev Ind Pharm; 2011 Feb; 37(2):149-59. PubMed ID: 20615154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
    Quinten T; Gonnissen Y; Adriaens E; De Beer T; Cnudde V; Masschaele B; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Sci; 2009 Jun; 37(3-4):207-16. PubMed ID: 19491007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation.
    Quinten T; De Beer T; Onofre FO; Mendez-Montealvo G; Wang YJ; Remon JP; Vervaet C
    J Pharm Sci; 2011 Jul; 100(7):2858-70. PubMed ID: 21254067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the permeability of metoprolol tartrate through plasticized isolated ethylcellulose/hydroxypropyl methylcellulose films and drug release from reservoir pellets.
    Ye ZW; Rombout P; Remon JP; Vervaet C; Van den Mooter G
    Eur J Pharm Biopharm; 2007 Sep; 67(2):485-90. PubMed ID: 17383166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release.
    Lopes CM; Sousa Lobo JM; Costa P; Pinto JF
    Drug Dev Ind Pharm; 2006 Jan; 32(1):95-106. PubMed ID: 16455608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.
    Quinten T; Andrews GP; De Beer T; Saerens L; Bouquet W; Jones DS; Hornsby P; Remon JP; Vervaet C
    AAPS PharmSciTech; 2012 Dec; 13(4):1197-211. PubMed ID: 22965662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cellulose ether polymers on ibuprofen release from matrix tablets.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2005 Aug; 31(7):653-65. PubMed ID: 16207613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
    Yang YP; Wang MY; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):291-6. PubMed ID: 23591354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naproxen release from sustained release matrix system and effect of cellulose derivatives.
    Sarfraz MK; Rehman NU; Mohsin S
    Pak J Pharm Sci; 2006 Jul; 19(3):251-5. PubMed ID: 16935834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and study of lamivudine oral controlled release tablets.
    Ravi PR; Ganga S; Saha RN
    AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.